CHINA PHARMA HOLDINGS, INC. Quarterly Interest Expense in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
China Pharma Holdings, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q3 2024.
  • China Pharma Holdings, Inc. Interest Expense for the quarter ending September 30, 2024 was $6.84K, a 1.43% decline year-over-year.
  • China Pharma Holdings, Inc. annual Interest Expense for 2023 was $334K, a 23.2% decline from 2022.
  • China Pharma Holdings, Inc. annual Interest Expense for 2022 was $435K, a 19.8% decline from 2021.
  • China Pharma Holdings, Inc. annual Interest Expense for 2021 was $542K, a 84.3% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.84K -$99 -1.43% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q4 2023 $334K $110K +$13.4K +13.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $320K $6.94K -$97K -93.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $417K $138K +$27.6K +25.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $390K $79.4K -$45K -36.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $435K $96.2K -$237K -71.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $672K $104K +$39.1K +60.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $633K $110K +$37.6K +52% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $595K $124K +$53.2K +74.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $542K $333K +$225K +209% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $317K $64.9K +$3.84K +6.28% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $313K $72.4K +$9.25K +14.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $303K $71.3K +$9.26K +14.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $294K $108K +$37.9K +54% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $256K $61.1K -$6.52K -9.65% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $263K $63.1K -$34.1K -35.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $297K $62K -$24.8K -28.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $322K $70.1K -$19.8K -22% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 $342K $67.6K -$34.1K -33.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $376K $97.3K -$33.3K -25.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $409K $86.8K -$42.3K -32.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $451K $89.9K -$37.5K -29.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $489K $102K -$29.1K -22.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $518K $131K -$11.6K -8.18% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $529K $129K -$9.86K -7.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $539K $127K -$507K -79.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 $1.05M $131K -$82.9K -38.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $1.13M $142K -$102K -41.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $1.23M $139K +$381K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 $850K $634K +$2.71M Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$1.87M $214K -$65.4K -23.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$1.8M $244K -$78.5K -24.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$1.72M -$242K -$556K -177% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$1.17M -$2.08M -$3.36M -262% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 $2.2M $279K +$604K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $1.59M $322K +$436K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $1.16M $314K +$370K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 $786K $1.28M +$1.53M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$745K -$325K -$236K -264% Jul 1, 2014 Sep 30, 2014 10-Q/A 2015-12-28
Q2 2014 -$509K -$113K -$21.3K -23.2% Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-12-28
Q1 2014 -$488K -$56.4K -$139K -168% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-12-28
Q4 2013 -$349K -$250K -$177K -243% Oct 1, 2013 Dec 31, 2013 10-K/A 2015-12-28
Q3 2013 -$172K -$89.2K -$9.73K -12.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$162K -$92K -$13.6K -17.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$148K $82.4K +$160K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$308K -$72.9K -$2.54K -3.61% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-20
Q3 2012 -$306K -$79.5K -$17.1K -27.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$289K -$78.5K -$17.3K -28.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$272K -$77.5K -$16.3K -26.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 -$255K -$70.3K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-14
Q3 2011 -$62.4K -$24.8K -65.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$61.2K -$9.59K -18.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$61.2K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q3 2010 -$37.7K Jul 1, 2010 Sep 30, 2010 10-Q/A 2012-03-06
Q2 2010 -$51.6K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.